|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.26 USD | -0.10% |
|
-2.01% | +26.77% |
| 08/12 | Why the Fed's Next Move Matters More Than Markets Admit |  |
| 08/12 | Analyst recommendations: 3M Company, Exxon Mobil, Mastercard, Netflix, Tesla… | |
Company Valuation: Medtronic plc
Data adjusted to current consolidation scope
| Fiscal Period: April | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,76,867 | 1,46,872 | 1,19,326 | 1,05,230 | 1,07,939 | 1,29,817 | - | - |
| Change | - | -16.96% | -18.76% | -11.81% | 2.57% | 20.27% | - | - |
| Enterprise Value (EV) 1 | 1,99,663 | 1,67,272 | 1,42,147 | 1,28,970 | 1,34,237 | 1,52,477 | 1,50,438 | 1,47,966 |
| Change | - | -16.22% | -15.02% | -9.27% | 4.08% | 13.59% | -1.34% | -1.64% |
| P/E ratio | 49.3x | 29.4x | 31.8x | 28.7x | 23.3x | 23.3x | 21.4x | 19.5x |
| PBR | 3.43x | 2.77x | 2.32x | 2.07x | 2.3x | 2.65x | 2.55x | 2.43x |
| PEG | - | 0.7x | -1.3x | -13.49x | 0.8x | 1.1x | 2.36x | 2.03x |
| Capitalization / Revenue | 5.87x | 4.64x | 3.82x | 3.25x | 3.22x | 3.6x | 3.4x | 3.23x |
| EV / Revenue | 6.63x | 5.28x | 4.55x | 3.98x | 4x | 4.23x | 3.94x | 3.69x |
| EV / EBITDA | 24.7x | 17x | 15.3x | 14x | 13.8x | 14.9x | 13.6x | 12.4x |
| EV / EBIT | 27.8x | 18.9x | 17.1x | 15.6x | 15.5x | 16.8x | 15.4x | 14.2x |
| EV / FCF | 40.9x | 28x | 31x | 24.8x | 25.9x | 26.1x | 22.7x | 20.4x |
| FCF Yield | 2.45% | 3.57% | 3.22% | 4.03% | 3.86% | 3.83% | 4.4% | 4.91% |
| Dividend per Share 2 | 2.32 | 2.72 | 2.72 | 2.8 | 2.8 | 2.844 | 2.966 | 3.063 |
| Rate of return | 1.77% | 2.48% | 3.03% | 3.53% | 3.33% | 2.81% | 2.93% | 3.02% |
| EPS 2 | 2.66 | 3.73 | 2.82 | 2.76 | 3.61 | 4.342 | 4.736 | 5.19 |
| Distribution rate | 87.2% | 72.9% | 96.5% | 101% | 77.6% | 65.5% | 62.6% | 59% |
| Net sales 1 | 30,117 | 31,686 | 31,227 | 32,364 | 33,537 | 36,058 | 38,140 | 40,132 |
| EBITDA 1 | 8,096 | 9,830 | 9,294 | 9,226 | 9,702 | 10,230 | 11,053 | 11,896 |
| EBIT 1 | 7,177 | 8,856 | 8,295 | 8,272 | 8,648 | 9,049 | 9,791 | 10,393 |
| Net income 1 | 3,606 | 5,039 | 3,758 | 3,676 | 4,662 | 5,396 | 6,042 | 6,574 |
| Net Debt 1 | 22,796 | 20,400 | 22,821 | 23,740 | 26,298 | 22,660 | 20,621 | 18,149 |
| Reference price 2 | 131.20 | 109.48 | 89.69 | 79.25 | 84.16 | 101.26 | 101.26 | 101.26 |
| Nbr of stocks (in thousands) | 13,48,073 | 13,41,539 | 13,30,424 | 13,27,823 | 12,82,544 | 12,82,014 | - | - |
| Announcement Date | 27/05/21 | 26/05/22 | 25/05/23 | 23/05/24 | 21/05/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.34x | 4.23x | 14.92x | 2.81% | 13TCr | |
| 31.45x | 4.96x | 18.65x | 1.9% | 22TCr | |
| 23.38x | 0.2x | 13.32x | 0.68% | 6.59TCr | |
| 28.56x | 3.15x | 10.81x | 2.11% | 5.54TCr | |
| 36.42x | 8.22x | 22.88x | 1.07% | 5.2TCr | |
| 32.38x | 4.57x | 16.52x | 0.93% | 2.58TCr | |
| 31.72x | 5.53x | 18.99x | -.--% | 2.55TCr | |
| 63.66x | 7.67x | 25x | 0.39% | 2.41TCr | |
| 24.91x | 3.1x | 12.4x | 1.26% | 2.25TCr | |
| 87.34x | 8.04x | 34.2x | -.--% | 2.14TCr | |
| Average | 38.31x | 4.97x | 18.77x | 1.11% | 6.4TCr | |
| Weighted average by Cap. | 32.03x | 4.58x | 17.48x | 1.65% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- MDT Stock
- Valuation Medtronic plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition